PSMA-PET/CT imaging in prostate cancer: why and when-Reference-Cited by-同舟云学术

PSMA-PET/CT imaging in prostate cancer: why and when

Published:2019-11-15 Issue:6 Volume:7 Page:377-379
ISSN:2281-5872
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

Ceci Francesco,Fanti Stefano

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s40336-019-00348-x.pdf

Reference11 articles.

1. Fendler WP, Eiber M, Beheshti M et al (2017) (68) Ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 44(6):1014–1024

2. Emmett L, Yin C, Crumbaker M et al (2019) Rapid modulation of PSMA expression by androgen deprivation: serial (68)Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade. J Nucl Med 60(7):950–954

3. Mottet N, van der Bergh RCN, Briers E, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. EAU Guidelines. Edn.In: presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2

4. Ceci F, Castellucci P, Graziani T et al (2019) (68)Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. Eur J Nucl Med Mol Imaging. 46(1):31–39

5. Calais J, Ceci F, Eiber M (2019) (18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 20(9):1286–1294

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy;Cancers;2023-09-13

2. Aptamer‐functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: A comprehensive overview of recent trends;Biotechnology Progress;2023-05-24

3. Baseline [68Ga]Ga-PSMA-11 PET/CT before [177Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions;Cancers;2023-01-12

4. Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy;In Vivo;2023

5. Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the 68Zn(p,n)68Ga Reaction and Their Regulatory Aspects;Pharmaceutics;2022-12-26